178 related articles for article (PubMed ID: 920768)
1. Oxytocinase and human placental lactogen for the prediction of intrauterine growth retardation.
Hensleigh PA; Cheatum SG; Spellacy WN
Am J Obstet Gynecol; 1977 Nov; 129(6):675-8. PubMed ID: 920768
[TBL] [Abstract][Full Text] [Related]
2. [Serum HPL, total estrogen excretion and serum oxytocinase in intrauterine retardation. Results of 3 evaluation procedures].
Kyank HR
Zentralbl Gynakol; 1983; 105(10):635-41. PubMed ID: 6880465
[TBL] [Abstract][Full Text] [Related]
3. The use of human placental lactogen, oxytocinase and estriol in twin pregnancies with intrauterine growth retardation.
Briët JW; Hoorn RK
Eur J Obstet Gynecol Reprod Biol; 1982 Feb; 13(1):7-14. PubMed ID: 7060818
[TBL] [Abstract][Full Text] [Related]
4. [Relationship between the biparietal diameter of the fetal head, human placental lactogen (HPL), thermostable alkaline phosphatase, and blood oxytocinase in risk pregnancy].
Lukacín S; Sedlák J; Rod J; Strozová A; Jurcová E; Fialová B
Bratisl Lek Listy; 1981 Feb; 75(2):179-84. PubMed ID: 7214183
[No Abstract] [Full Text] [Related]
5. Plasma human placental lactogen, oxytocinase, and placental phosphatase in normal and toxemic pregnancies.
Spellacy WN; Usategui-Gomez M; Fernandez-deCastro A
Am J Obstet Gynecol; 1977 Jan; 127(1):10-6. PubMed ID: 188338
[TBL] [Abstract][Full Text] [Related]
6. Further investigation on the predictive value of human placental lactogen in high-risk pregnancies.
Granat M; Sharf M; Diengott D; Spindel A; Kahana L; Elrad H
Am J Obstet Gynecol; 1977 Nov; 129(6):647-54. PubMed ID: 920766
[TBL] [Abstract][Full Text] [Related]
7. The role of human placental lactogen assays in antepartum fetal assessment.
Morrison I; Green P; Oomen B
Am J Obstet Gynecol; 1980 Apr; 136(8):1055-60. PubMed ID: 7369258
[TBL] [Abstract][Full Text] [Related]
8. [Management of fetuses in the late pregnancy by serial determinations of serum human placental lactogen levels].
Kaibara M; Marumoto Y; Taniguchi I; Kobayashi T
Nihon Sanka Fujinka Gakkai Zasshi; 1982 Oct; 34(10):1724-8. PubMed ID: 7175278
[TBL] [Abstract][Full Text] [Related]
9. Use of hPL in the diagnosis of intrauterine growth retardation.
Gohari P; Hobbins JC; Berkowtiz R
Obstet Gynecol; 1978 Jul; 52(1):127-8. PubMed ID: 683623
[TBL] [Abstract][Full Text] [Related]
10. An evaluation of human placental lactogen levels in hypertension of pregnancy.
Kelly AM; England P; Lorimer JD; Ferguson JC; Govan AD
Br J Obstet Gynaecol; 1975 Apr; 82(4):272-7. PubMed ID: 1168483
[TBL] [Abstract][Full Text] [Related]
11. Value of total serum oestriol and human placental lactogen in the assessment of fetal-placental function.
Isouard G
Aust N Z J Obstet Gynaecol; 1979 May; 19(2):69-76. PubMed ID: 292431
[TBL] [Abstract][Full Text] [Related]
12. Cystyl aminopeptidase in maternal serum for the antenatal recognition of fetal growth retardation.
Gopalaswamy G; Balasubramaniam N; Kanagasabapathy AS
Aust N Z J Obstet Gynaecol; 1983 May; 23(2):79-84. PubMed ID: 6578781
[TBL] [Abstract][Full Text] [Related]
13. Maternal blood levels of human placental lactogen in the prediction of fetal growth retardation: choosing a cut-off point between normal and abnormal.
Lilford RJ; Obiekwe BC; Chard T
Br J Obstet Gynaecol; 1983 Jun; 90(6):511-5. PubMed ID: 6860597
[TBL] [Abstract][Full Text] [Related]
14. Placental protein measurements in complicated pregnancies. I. Intrauterine growth retardation.
Westergaard JG; Teisner B; Hau J; Grudzinskas JG
Br J Obstet Gynaecol; 1984 Dec; 91(12):1216-23. PubMed ID: 6083800
[TBL] [Abstract][Full Text] [Related]
15. Hormonal placental functions and intrauterine growth retardation in patients with positive contraction stress tests.
Odendaal HJ; Malan C; Oosthuizen J
S Afr Med J; 1981 May; 59(23):822-4. PubMed ID: 7233299
[TBL] [Abstract][Full Text] [Related]
16. Which is the best placental function test? A comparison of placental lactogen and unconjugated oestriol in the prediction of intrauterine growth retardation.
Chard T; Sturdee J; Cockrill B; Obiekwe BC
Eur J Obstet Gynecol Reprod Biol; 1985 Jan; 19(1):13-7. PubMed ID: 3979650
[TBL] [Abstract][Full Text] [Related]
17. Use of curves for prediction of maternal blood levels of placenta-specific substances for diagnosis of placental function.
Yamaguchi R; Ueda H; Shimozato N; Tsuji Y; Amano A
Tohoku J Exp Med; 1979 Jul; 128(3):201-7. PubMed ID: 315114
[TBL] [Abstract][Full Text] [Related]
18. [Placental (HPL, HSAP, CAP) and fetal (estriol in urine and blood) parameters in high risk pregnancies].
Battaglia GB; Morresi G; Coronella L; Messeri G; Valenza T
Quad Sclavo Diagn; 1977 Dec; 13(4):434-48. PubMed ID: 351694
[No Abstract] [Full Text] [Related]
19. [Concentrations of total oestriol, non-conjugated oestriol, human placental lactogen and oxytocinase in the serum, and total oestrogens in the urine of pregnant women, following the administration of betamethasone (author's transl)].
Knoll E; Kayser A; Wisser H
J Clin Chem Clin Biochem; 1978 Nov; 16(11):621-4. PubMed ID: 731194
[TBL] [Abstract][Full Text] [Related]
20. Plasma oestriol and human placental lactogen measurements in patients with high risk pregnancies.
Edwards RP; Diver MJ; Davis JC; Hipkin LJ
Br J Obstet Gynaecol; 1976 Mar; 83(3):229-37. PubMed ID: 1252389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
